These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 9071918)
1. 13-cis-retinoic acid and alpha-interferon in advanced squamous cell cancer of the oesophagus. Kok TC; van der Gaast A; Splinter TA Eur J Cancer; 1997 Jan; 33(1):165-6. PubMed ID: 9071918 [No Abstract] [Full Text] [Related]
2. 13-cis-retinoic acid plus interferon-alpha 2a in locally advanced squamous cell carcinoma of the cervix. Lippman SM; Kavanagh JJ; Paredes-Espinoza M; Delgadillo-Madrueño F; Paredes-Casillas P; Hong WK; Massimini G; Holdener EE; Krakoff IH J Natl Cancer Inst; 1993 Mar; 85(6):499-500. PubMed ID: 8445678 [No Abstract] [Full Text] [Related]
3. 13-Cis-retinoic acid and interferon alpha-2a in patients with advanced esophageal cancer: a phase II trial. Slabber CF; Falkson G; Burger W; Schoeman L Invest New Drugs; 1996; 14(4):391-4. PubMed ID: 9157075 [TBL] [Abstract][Full Text] [Related]
4. Combination of alpha-interferon 2a (alpha-IFN 2a) and 13-cis-retinoic acid (13cRA) in recurrent, pre-treated squamous-cell carcinoma of head and neck (SCCHN). Toma S; Airoldi M; Palumbo R; Raffo P; Bumma C Int J Cancer; 1997 Feb; 70(4):491-3. PubMed ID: 9033664 [No Abstract] [Full Text] [Related]
5. Phase II clinical trial of 13-cis-retinoic acid and interferon-alpha-2a in patients with advanced esophageal carcinoma. Enzinger PC; Ilson DH; Saltz LB; Martin LK; Kelsen DP Cancer; 1999 Mar; 85(6):1213-7. PubMed ID: 10189124 [TBL] [Abstract][Full Text] [Related]
6. 13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. Lippman SM; Parkinson DR; Itri LM; Weber RS; Schantz SP; Ota DM; Schusterman MA; Krakoff IH; Gutterman JU; Hong WK J Natl Cancer Inst; 1992 Feb; 84(4):235-41. PubMed ID: 1734084 [TBL] [Abstract][Full Text] [Related]
7. 13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix. Lippman SM; Kavanagh JJ; Paredes-Espinoza M; Delgadillo-Madrueño F; Paredes-Casillas P; Hong WK; Holdener E; Krakoff IH J Natl Cancer Inst; 1992 Feb; 84(4):241-5. PubMed ID: 1734085 [TBL] [Abstract][Full Text] [Related]
8. A phase II study of 13-cis retinoic acid plus interferon alpha-2a in advanced stage penile carcinoma: an Eastern Cooperative Oncology Group study (E3893). Skeel RT; Huang J; Manola J; Wilding G; Dreicer R; Walker P; Muggia F; Crawford ED; Dutcher JP; Loehrer PJ Cancer Invest; 2003; 21(1):41-6. PubMed ID: 12643008 [TBL] [Abstract][Full Text] [Related]
9. Phase II trial of 13-cis-retinoic acid plus interferon-alpha in recurrent head and neck cancer. Voravud N; Lippman SM; Weber RS; Rodriquez GI; Yee D; Dimery IW; Earley CL; Von Hoff DD; Hong WK Invest New Drugs; 1993 Feb; 11(1):57-60. PubMed ID: 8349437 [TBL] [Abstract][Full Text] [Related]
10. A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma. Ilson DH; Sirott M; Saltz L; Heelan R; Huang Y; Keresztes R; Kelsen DP Cancer; 1995 May; 75(9):2197-202. PubMed ID: 7712428 [TBL] [Abstract][Full Text] [Related]
11. Response to 13-cis-retinoic acid plus interferon alfa-2a in two patients with therapy-refractory advanced renal cell carcinoma. Buer J; Probst M; Ganser A; Atzpodien J J Clin Oncol; 1995 Oct; 13(10):2679-80. PubMed ID: 7595723 [No Abstract] [Full Text] [Related]
12. Efficacy of recombinant alpha-interferon 2a and 13-cis-retinoic acid in the treatment of squamous cell carcinoma. Toma S; Palumbo R; Vincenti M; Aitini E; Paganini G; Pronzato P; Grimaldi A; Rosso R Ann Oncol; 1994 May; 5(5):463-5. PubMed ID: 8075053 [TBL] [Abstract][Full Text] [Related]
13. Treatment of carcinoma of the esophagus with 5-fluorouracil and recombinant alfa-2a-interferon. Wadler S; Fell S; Haynes H; Katz HJ; Rozenblit A; Kaleya R; Wiernik PH Cancer; 1993 Mar; 71(5):1726-30. PubMed ID: 8448736 [TBL] [Abstract][Full Text] [Related]
14. Oxygenation of cervical cancers during radiotherapy and radiotherapy + cis-retinoic acid/interferon. Dunst J; Hänsgen G; Lautenschläger C; Füchsel G; Becker A Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):367-73. PubMed ID: 10030263 [TBL] [Abstract][Full Text] [Related]
15. 13-Cis-retinoic acid plus interferon-alpha 2a in recurrent respiratory papillomatosis. Lippman SM; Donovan DT; Frankenthaler RA; Weber RS; Earley CL; Hong WK; Goepfert H J Natl Cancer Inst; 1994 Jun; 86(11):859-61. PubMed ID: 8182767 [No Abstract] [Full Text] [Related]
16. Phase II trial of 13-cis retinoic acid plus interferon-alpha in advanced squamous cell carcinoma of head and neck, refractory to chemotherapy. Cascinu S; Del Ferro E; Ligi M; Graziano F; Castellani A; Catalano G Ann Oncol; 1996 Jul; 7(5):538. PubMed ID: 8839916 [No Abstract] [Full Text] [Related]
17. Prolonged stabilization of progressive squamous cell cancer of the cervix with interferon-alpha and 13-cis-retinoic acid: report of two cases and review of the literature. Piamsomboon S; Termrungruanglert W; Kudelka AP; Edwards CL; Freedman RS; Mountain CF; Delclos L; Aapro MS; DeCaro L; Bianca J; Verschraegen CF; Kavanagh JJ Anticancer Drugs; 1996 Sep; 7(7):800-4. PubMed ID: 8949994 [TBL] [Abstract][Full Text] [Related]
18. Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial. Shin DM; Khuri FR; Murphy B; Garden AS; Clayman G; Francisco M; Liu D; Glisson BS; Ginsberg L; Papadimitrakopoulou V; Myers J; Morrison W; Gillenwater A; Ang KK; Lippman SM; Goepfert H; Hong WK J Clin Oncol; 2001 Jun; 19(12):3010-7. PubMed ID: 11408495 [TBL] [Abstract][Full Text] [Related]
19. Unresectable perineal cuniculatum carcinoma: partial remission using systemic isotretinoin and interferon-α2a therapy. Tauber M; Monsel G; Bonnecarrère L; Battistella M; Cordel N; Honein C; Aubin F; Bagot M; Petit A; Lebbé C; Viguier M Acta Derm Venereol; 2014 Nov; 94(6):721-2. PubMed ID: 24676771 [No Abstract] [Full Text] [Related]
20. Interferon-alpha 2a, 13-cis-retinoic acid and radiotherapy for locally advanced carcinoma of the cervix: a pilot study. Park TK; Lee JP; Kim SN; Choi SM; Kudelka AP; Kavanagh JJ Eur J Gynaecol Oncol; 1998; 19(1):35-8. PubMed ID: 9476056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]